| Affymax and Takeda Report Additional Phase 3 Clinical Trial (AFFY) - Benzinga |
|
|
Benzinga Affymax (Nasdaq: AFFY) and Takeda Pharmaceutical Company Limited , today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with ... Affymax and Takeda Report Additional Phase 3 Clinical Trial Data for |